Taiwan & United States — Food and Drug Administration

Taiwan: Taiwan is the headquarters of Jyong Biotech and the location of its R&D subsidiary, Health Ever Biotech, playing a role in clinical trials and scientific development.

United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) approval is a critical milestone for Jyong Biotech's lead drug candidates, as it enables market access and sets a precedent for global regulatory pathways.

Taiwan: Taiwan is highlighted as the origin of the ingenuity behind NaoTrac>>>, showcasing its contribution to global health innovation.

United States — Food and Drug Administration: The United States — Food and Drug Administration>>> is one of the regulatory bodies that has approved NaoTrac>>>, indicating its safety and quality for use in the United States.